The safety and feasibility of multiple intrathecal injections of allogenic NK cells in pediatrics with refractory/recurrent brain tumors

Authors
Category Primary study
JournalBMC Cancer
Year 2025
This article has no abstract
Epistemonikos ID: ae03a2d1b26cfe409608a6cd20e0409d4f334db4
First added on: Jun 13, 2025